{"schema":"hottub-news/story/v1","story":"st_qycunmgth4qz5j5f4o6q","title":"ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/rosen-national-investor-counsel-encourages-unicycive-therapeutics-inc-qycunmgth4","count":1,"items":[{"id":"n_qycunmgth4qz5j5f4o6q","seq":1449706,"kind":"press_release","title":"ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY","url":"https://www.globenewswire.com/news-release/2026/10/02/3374076/673/en/rosen-national-investor-counsel-encourages-unicycive-therapeutics-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-uncy.html","summary":"NEW YORK, Oct. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between December 29, 2025 and June 29, 2026, both dates inclusive (the “Class Period”), of the important November 2, 2026 lead plaintiff deadline.","published":"2026-10-02T23:34:00Z","seen":"2026-10-02T23:46:22Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q139379676","name":"Unicycive Therapeutics, Inc.","type":"org"}],"story":"st_qycunmgth4qz5j5f4o6q","category":"economy-business","category_p":0.6000000238418579,"sentiment":"neutral","tone":-0.07000000029802322,"political":0.20999999344348907}]}